Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

An IV infusion clinic in Cullman has been court ordered to temporarily close its doors after being accused of administering ...

ATLANTA — Tirzepatide appeared highly effective in reducing weight among women with polycystic ovary syndrome (PCOS) and overweight or obesity, real-world data from a retrospective analysis of over ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsBrian Luque - Head of Investor Relations & ...

Elizabeth Zinni is facing two counts of sale or use of drugs not approved by the Food and Drug Administration, fifth-degree ...

New research from the Technical University of Munich and Harvard Medical School reveals that popular GLP-1-based drugs, ...

Subcutaneous dulaglutide, semaglutide, and tirzepatide demonstrated a similar GI safety among patients with type 2 diabetes.

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study ...

Cardiovascular disease still claims more lives than any other illness, and many adults living with obesity or type 2 diabetes carry a heavy risk of heart attack and stroke. Two medications, ...

Innovative biopharmaceutical company Metsera ( MTSR 0.10%) has been climbing all year. It went public on Feb. 3 of this year, ...

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh. Who is winning?

Tirzepatide was linked to improved weight loss outcomes in patients with PCOS, especially those who used a digital weight ...